Skip to main content
. 2020 Sep 2;319(5):G584–G588. doi: 10.1152/ajpgi.00135.2020

Table 1.

Baseline patient demographics

Cirrhosis Patients (n = 5 patients) Pancreatic Cancer Patients (n = 7 patients) P Value
Age, yr 56.0 (± 11.2) 61 (± 9.7) 0.76
Males, % 60 (n = 3) 57 (n = 4 patients) 0.56
Disease etiology, % Alcohol: 60 (n = 3 patients)
NAFLD: 40 (n = 2 patients)
PDAC: 100% (n = 7 patients)
Disease stage, % Compensated: 60 (n = 3 patients)
Decompensated: 40 (n = 2 patients)
Stage 2: 29 (n = 2 patients)
Stage 3: 29 (n = 2 patients)
Stage 4: 42 (n = 3 patients)
Current smoker, % 40 (n = 2 patients) 14 (n = 1 patients) 0.45
BMI, kg/m2 24.3 (± 5.4) 28.7 (± 6.8) 0.67
History of diabetes, % 40 (n = 2 patients) 57% (n = 4 patients) 0.87

Total patients, n = 12. NAFLD, nonalcoholic fatty liver disease; PDAC, pancreatic ductal adenocarcinoma.